ClinicalTrials.gg
Status unknownNCT02539381Updated Sep 3, 2015

The Stroke Vision App: A Screening Tool for Visual Stroke

An interventional study of Formal Perimetry (Goldman or Octopus visual Field) and Albert's visual inattention test in Eye Abnormalities and Stroke, sponsored by NHS Greater Glasgow and Clyde. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-09-03.

Sponsored by NHS Greater Glasgow and Clyde · Not applicable, Interventional, and Screening

The sponsor has not verified this record recently (last verified Aug 2015), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Visual impairment can affect up to 70% of stroke survivors, but many do not have their vision adequately assessed in hospital. An unidentified visual defect can cause significant problems for recovery and quality of life. The Stroke Vision app (an application currently scaled for a 10" Android tablet) has been developed to act as a screening tool for visual problems in stroke survivors; to help identify visual problems earlier and thereby improve rehabilitation outcomes. The app includes a suite of tests for assessing the patient's acuity, their visual fields and to aid in the identification of visual neglect / inattention. Furthermore, it includes educational information on visual stroke in order to better educate staff, patients and their carers. This study seeks to validate the novel digital assessments included in the Stroke Vision app against the current methods used for screening (clinical examination by confrontation field testing). Both screening measures will be compared with the gold standard methods for visual assessments, Octopus perimetry for fields and paper-based methods for visuospatial neglect

02

Conditions studied

  • Eye Abnormalities
  • Stroke
03

In context

Eye Abnormalities

28 studies on the registry are indexed under Eye Abnormalities; 3 are open to participants now.

This study's planned enrollment of 62 is above the median of 22 across 13 interventional studies indexed under Eye Abnormalities.

Browse Eye Abnormalities studies →

Lead sponsor

NHS Greater Glasgow and Clyde is the lead sponsor of 220 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients referred to Visual Stroke Orthoptic Clinics
  • All patients with stroke or stroke-like visual problems (for example, but not limited to bitemporal hemianopia caused by pituitary adenoma) referred to the neuro-ophthalmology clinics.
  • Consent Provided

Exclusion criteria

Exclusion Criteria:

  • No spoken English
  • Unable to provide consent
  • Profound cortical blindness
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
62 participants (estimated)

Study arms

  • Other
    Gold Standard Assessments

    * Formal perimetry (Goldman or Octopus visual field) * Albert's visual inattention test * Star cancellation visual inattention test * line bisection test * These are performed as part of the routine assessment in the visual stroke orthoptic clinic and neuro-ophthalmology clinics. * The time to perform the assessments or if the participant is unable to complete the assessment will be recorded. * Researcher will record a score (0-10) to quantify the participant's compliance

    Procedure: Formal Perimetry (Goldman or Octopus visual Field) · Procedure: Albert's visual inattention test · Procedure: Star cancellation visual inattention test

  • Other
    Usual Clinical Screening Practice

    * Visual field assessment to confrontation * Visual inattention assessment to bilateral stimuli * The time to perform the assessments or if the participant is unable to complete the assessment will be recorded. * Researcher will record a score (0-10) to quantify the participant's compliance

    Procedure: Visual field assessment to confrontation · Procedure: Visual inattention assessment to bilateral stimuli

  • Other
    Stroke Vision App

    * Digital tumbling E visual accuity assessment * Digital visual field assessment * Digital line crossing assessment * Digital shape cancellation assessment * The time to perform the assessments or if the participant is unable to complete the assessment will be recorded. * Researcher will record a score (0-10) to quantify the participant's compliance

    Device: Digital tumbling E visual accuity assessment · Device: Digital visual field assessment · Device: Digital line crossing assessment · Device: Digital shape cancellation assessment

Interventions

  • ProcedureFormal Perimetry (Goldman or Octopus visual Field)
  • ProcedureAlbert's visual inattention test
  • ProcedureStar cancellation visual inattention test
  • ProcedureVisual field assessment to confrontation
  • ProcedureVisual inattention assessment to bilateral stimuli
  • DeviceDigital tumbling E visual accuity assessment
  • DeviceDigital visual field assessment
  • DeviceDigital line crossing assessment
  • DeviceDigital shape cancellation assessment
06

What researchers measure

Primary outcomes

  1. Accuracy of Stroke Vision Tablet App to support assessment of visual field defects when compared with visual field assessment to confrontation in standard clinical practice

    Visual field will be captured either by the Stroke Vision App or by confrontation. Visual field will be reported by assessors (blinded to referral and comparator assessment) as either defect present, no defect present or unable to test. Agreement between visual field assessment supported by the Stroke Vision App and visual field assessment to confrontation in standard clincial practice will be quantified by the Kappa statistic. Accuracy metrics of sensitivity/specificity/predictive values will also be reported.

    Time frame: All assessments will be conducted following consent at standard clinical assessment visit

  2. Accuracy of Stroke Vision Tablet App to support assessment of visual inattention defects when compared to visual inattention assessment to bilateral stimuli in standard clinical practice

    Visual inattention tests will be conducted either by the Stroke Vision App or by inattention to bilateral stimuli in standard clinical practice. Inattention will be reported by assessors (blinded to referral and comparator assessment) as either defect present, no defect present or unable to test. Agreement between visual inattention assessment supported by the Stroke Vision App and inattention to bilateral stimuli in standard clincial practice will be quantified by the Kappa statistic. Accuracy metrics of sensitivity/specificity/predictive values will also be reported.

    Time frame: All assessments will be conducted following consent at standard clinical assessment visit

Secondary outcomes

  1. Accuracy of Stroke Vision Tablet App to support assessment of visual field defects when compared with "Gold standard" formal perimetry assessments

    Visual field will be captured either by the Stroke Vision App or by formal perimetry assessments. Visual field will be reported by assessors (blinded to referral and comparator assessment) as either defect present, no defect present or unable to test. Agreement between visual field assessment supported by the Stroke Vision App and visual field assessment to formal perimetry will be quantified by the Kappa statistic. Accuracy metrics of sensitivity/specificity/predictive values will also be reported.

    Time frame: All assessments will be conducted following consent at standard clinical assessment visit

  2. Accuracy of Stroke Vision Tablet App to support assessment of visual inattention defects when compared with "Gold standard" Albert's visual inattention test, Star cancellation visual inattention test, Line Bisection test

    Visual inattention tests will be conducted either by the Stroke Vision App or by Gold standard" Albert's visual inattention test, Star cancellation visual inattention test, Line Bisection test conducted by a clinician. Inattention will be reported by assessors (blinded to referral and comparator assessment) as either defect present, no defect present or unable to test. Agreement between visual inattention assessment supported by the Stroke Vision App and "Gold standard" Albert's visual inattention test, Star cancellation visual inattention test, Line Bisection test will be quantified by the Kappa statistic. Accuracy metrics of sensitivity/specificity/predictive values will also be reported.

    Time frame: All assessments will be conducted following consent at standard clinical assessment visit

Other outcomes

  1. Proportion of patients completing Gold standard vision assessments

    Time frame: All assessments will be conducted following consent at standard clinical assessment visit

  2. Proportion of patients competing usual clinical practice vision assessments

    Time frame: All assessments will be conducted following consent at standard clinical assessment visit

  3. Proportion of patients competing Stroke vision app assessments

    Time frame: All assessments will be conducted following consent at standard clinical assessment visit

  4. Time to complete Gold standard vision assessments

    Time frame: All assessments will be conducted following consent at standard clinical assessment visit

  5. Time to complete usual clinical practice vision assessments

    Time frame: All assessments will be conducted following consent at standard clinical assessment visit

  6. Time to complete Stroke vision app assessments

    Time frame: All assessments will be conducted following consent at standard clinical assessment visit

07

Study locations

1 of 1 sites recruiting
  • Gartnavel General Hospital
    Glasgow, Scotland G12 0YN, United Kingdom
    Recruiting
08

References and documents

Publications

  • Quinn TJ, Livingstone I, Weir A, Shaw R, Breckenridge A, McAlpine C, Tarbert CM. Accuracy and Feasibility of an Android-Based Digital Assessment Tool for Post Stroke Visual Disorders-The StrokeVision App. Front Neurol. 2018 Mar 28;9:146. doi: 10.3389/fneur.2018.00146. eCollection 2018. PubMed 29643830 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02539381
Responsible party
Sponsor
First posted
Sep 3, 2015
Start date
Jul 2015
Primary completion
Jan 2016 (estimated)
Completion
Jan 2016 (estimated)
Last update
Sep 3, 2015

Study contacts

Christine McAlpine, MBChB FRCP
Contact
christine.mcalpine@ggc.scot.nhs.uk
44-141-211-4843
Christine McAlpine, MBChB FRCP
principal investigator · NHS Greater Glasgow & Clyde

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion